InvestorsHub Logo

Jisep

12/31/20 9:40 AM

#62016 RE: Sage7243 #62013

SS doesn’t matter in biotechs

MAGA_PATRIOT

12/31/20 9:44 AM

#62020 RE: Sage7243 #62013

Fully diluted, $10 would only give them a $30B MC, which is nothing for a biotech, especially one that potentially holds the cure to HIV, Covid, and many others.

brezlin

12/31/20 9:48 AM

#62023 RE: Sage7243 #62013

Sage... of course none of us know... speculation as are ALL stocks. Can say as fact, however, that the estimated world market for HIV drugs is over $100B. Prob a lot higher. $ENZC has 3B AS. Fully diluted that’s $30+/share. If their CLONE3 will STOP HIV with a limited treatment for life as they say, nobody will go anywhere else for treatment. They’ll OWN it.

Now if Big Pharma wants a piece of CLONE3 and ITV1, not only for HIV solutions, but for Covid, Influenza and all of the others on their list that they feel are treatable with their disruptive, Patented tech..... the price can just keep going up.

This is Biotech and Big Pharma stuff. The stock price rarely reflects the kind of business #rs you’d calculate for say Micron. Look at Tesla! WAY overpriced....

If $ENZC has a CURE for HIV or can STOP Coronavirus, trust me, the stock price will reflect the semi loads of cash that’ll be coming in, not what the register says at the end of the day...